Versant Venture Capital VI, L.P. 13D and 13G filings for Tempest Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-11 5:58 pm Unchanged |
2024-11-12 | 13D | Tempest Therapeutics, Inc. TPST |
Versant Venture Capital VI, L.P. | 2,118,644 4.800% |
0 (Unchanged) |
Filing |
| 2024-08-12 8:59 pm Unchanged |
2024-08-08 | 13D | Tempest Therapeutics, Inc. TPST |
Versant Venture Capital VI, L.P. | 2,118,644 8.400% |
0 (Unchanged) |
Filing |
| 2024-05-13 4:54 pm Unchanged |
2024-03-19 | 13D | Tempest Therapeutics, Inc. TPST |
Versant Venture Capital VI, L.P. | 2,118,644 9.500% |
0 (Unchanged) |
Filing |
| 2024-02-08 5:41 pm Unchanged |
2023-11-08 | 13D | Tempest Therapeutics, Inc. TPST |
Versant Venture Capital VI, L.P. | 2,118,644 11.000% |
0 (Unchanged) |
Filing |
| 2023-11-09 5:28 pm Unchanged |
2023-08-10 | 13D | Tempest Therapeutics, Inc. TPST |
Versant Venture Capital VI, L.P. | 2,118,644 15.900% |
0 (Unchanged) |
Filing |
| 2022-05-09 5:26 pm Purchase |
2022-04-29 | 13D | Tempest Therapeutics, Inc. TPST |
Versant Venture Capital VI, L.P. | 2,118,644 20.500% |
940,173 (+79.78%) |
Filing |
| 2022-02-10 7:41 pm Purchase |
2021-12-31 | 13G | Tempest Therapeutics, Inc. TPST |
Versant Venture Capital VI, L.P. | 1,178,471 17.100% |
1,178,471 (New Position) |
Filing |